Don Smith, MD
Anesthesiology · Cordele, GANPI 1053329268
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Among anesthesiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$743
- AbbVie$542
- Scilex Pharmaceuticals Inc.$424
- Pfizer$299
- Collegium Pharmaceutical, Inc.$290
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$207
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,781100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 19 | $743 |
| AbbVie(2 entities) | 33 | $542 |
| Scilex Pharmaceuticals Inc. | 22 | $424 |
| Pfizer | 16 | $299 |
| Collegium Pharmaceutical, Inc. | 17 | $290 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $207 |
| Almatica Pharma LLC | 10 | $179 |
| Amgen | 9 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $135 |
| Lilly USA, LLC | 8 | $133 |
| Novartis | 4 | $75 |
| Averitas Pharma Inc. | 2 | $66 |
| Redhill Biopharma Inc. | 4 | $60 |
| Eisai Inc. | 3 | $54 |
| Pacira Therapeutics, Inc. | 3 | $44 |
| Johnson & Johnson | 2 | $44 |
| Sentynl Therapeutics, Inc. | 3 | $40 |
| Biohaven Pharmaceuticals, Inc. | 2 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Nalu Medical, Inc. | 2 | $28 |
| IBSA Pharma Inc. | 2 | $28 |
| Astellas Pharma US Inc | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Vertex | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $13 |
| AstraZeneca | 1 | $12 |
| Shionogi Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,781 in reported general payments places this provider in the 95th percentile of 1,137 anesthesiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 85 | $200,706 |
| Xtampza ErOxycodone Myristate | 159 | $127,479 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 3,159 | $107,033 |
| LinzessLinaclotide | 114 | $60,908 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,580 | $48,571 |
| MovantikNaloxegol Oxalate | 96 | $39,710 |
| ZtlidoLidocaine | 95 | $36,700 |
| Fentanyl | 336 | $32,107 |
| Oxycodone Hcl | 1,337 | $28,686 |
| Piroxicam | 50 | $28,517 |
| Aimovig AutoinjectorErenumab-Aooe | 32 | $24,170 |
| Gabapentin | 1,943 | $22,074 |
| OxycontinOxycodone Hcl | 30 | $19,432 |
| UbrelvyUbrogepant | 16 | $18,785 |
| Calcipotriene | 55 | $18,618 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $207 | $200,70685 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $290 | $127,479159 claims |
| AbbVieLinzess, Ubrelvy, Qulipta | $542 | $92,991141 claims |
| Redhill Biopharma Inc.Movantik | $60 | $39,71096 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $424 | $36,70095 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,137 anesthesiology providers in Georgia.
Other anesthesiology in Cordele
- Guy YoungCordele$3K
- Margaret HoltzMarietta$622K
- Mark HamiltonAtlanta$351K
- Michael AshmoreAtlanta$214K
- Jessica McCabeJohns Creek$62K
- Stephen KushinsLawrenceville$62K
- Uma ShastriAtlanta$35K
- Jessica McCounRome$34K
- Amit PatelLawrenceville$17K
- Melat GebreAtlanta$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.